Why CAMP4?
Leadership
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Investors
Newsroom
Join the Adventure
Recent News
October 11, 2024
Camp4 CEO credits CFO, investors’ ‘risk appetite’ for IPO
Read More
Contact Us
Privacy Policy
Terms of Use
Menu
20th July 2022
CAMP4 Charts A Different Course In RNA-Based Therapeutics
20th July 2022
CAMP4 Brings $100M to Target the Dark Side of the Genome with regRNA Platform
19th July 2022
The Dark Genome: The Next Frontier
19th July 2022
AI + Genetics: Unlocking Vast Possibilities
19th July 2022
Turning Gene Control Into Patient Impact
7th July 2022
EPIC proportions of discovery: CAMP4’s AI model for identifying regRNA targets
Newer
1
2
Top